Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: A meta-analysis.
The applications of liquid biopsy have attracted much attention in biomedical research in recent years. Circulating cell-free DNA (cfDNA) in the serum may serve as a unique tumor marker in various types of cancer. Circulating tumor DNA (ctDNA) is a type of serum cfDNA found in patients with cancer a...
Main Authors: | Yulan Gu, Chuandan Wan, Jiaming Qiu, Yanhong Cui, Tingwang Jiang, Zhixiang Zhuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0224001 |
Similar Items
-
Tissue-based metabolomics reveals potential biomarkers for cervical carcinoma and HPV infection
by: Abulizi Abudula, et al.
Published: (2019-08-01) -
Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives
by: Eriseld Krasniqi, et al.
Published: (2021-04-01) -
New HPV16 viral biomarkers to understand the progression of cervical lesions towards cancer
by: Jean-Luc Pretet, et al.
Published: (2014-01-01) -
Triage High Risk HPV Infected Women With Methylation Biomarker For Cervical Cancer Screening
by: Par Bahadur Pun, et al.
Published: (2015) -
Discovery of key genes as novel biomarkers specifically associated with HPV-negative cervical cancer
by: Yi Liu, et al.
Published: (2021-06-01)